Status:
COMPLETED
Improvement in Clinical Outcomes in Heart Failure Patients With ICDs That Practice Meditation
Lead Sponsor:
University of California, Davis
Conditions:
Congestive Heart Failure
Cardiac Resynchronization Therapy
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a trial to examine the effects of meditation on the incidence of ventricular arrhythmias and the psychological profiles in patients with implanted cardiac defibrillators. We wish to test the ...
Detailed Description
This is a single center, investigator-initiated, randomized, controlled trial to examine the effects of meditation on the incidence of ventricular arrhythmias and the psychological profiles in patient...
Eligibility Criteria
Inclusion
- Men and women aged 18 to 85
- All patients with NYHA class II to III congestive heart failure symptoms from ischemic and non-ischemic etiology who received a defibrillator at least 3 months prior to enrollment.
- All patients with NYHA class III and IV symptoms, QRS complex of the ECG more than 120 ms, who received device for cardiac resynchronization at least 3 months prior to enrollment. These devices are placed when the two ventricles beat at slightly different times. These devices also have the capacity to record arrhythmias as the defibrillators.
Exclusion
- Patients with life expectancy less than 6 months from non-cardiac causes
- Pregnant women
- Smokers
- History of major psychosis.
- Significant chronic liver, renal and pulmonary disease
- Active alcohol and drug abuse
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00611260
Start Date
April 1 2007
End Date
February 1 2012
Last Update
May 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Medical Center
Sacramento, California, United States, 95817